feedback

Activity Details

Free CME
0.5 AMA PRA Category 1 Credit(s)
Released: June 26, 2020
Expires: June 25, 2021
30 minutes to complete

Accredited By

Target Audience

Rheumatologists, dermatologists, pulmonologists, primary care providers, and other health care providers who manage patients with ILD.

Learning Objectives

Systemic sclerosis ILD

  • Describe changes over disease course
  • Explain monitoring and testing
  • Recognize comorbidities
  • Discuss new treatment options

Chronic progressive fibrosing ILD

  • Recognize diagnostic characteristics and differential diagnosis
  • Explain extant medications and their limitations
  • Discuss therapies on the horizon

Activity Description

Listen to experts report on current publications, posters, and sessions from a recent rheumatology conference. Faculty discuss the latest on systemic sclerosis ILD and progressive fibrosing ILD and discuss the implication of this information on current clinical practices for clinicians.

Faculty

Anca D. Askanase, MD, MPH
Associate Professor of Medicine
Columbia University Irving Medical Center
New York, New York


Robin Dore, MD
Clinical Professor of Medicine
UCLA David Geffen School of Medicine
Los Angeles, California


Eric L. Matteson, MD
Professor of Medicine
Division of Rheumatology, Department of Internal Medicine
Mayo Clinic
Rochester, Minnesota


Elizabeth Volkmann, MD, MS
Clinical Instructor
Department of Medicine, Division of Rheumatology
University of California, Los Angeles
Los Angeles, California


Conflict of Interest Policy/Disclosure Statement

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

The following faculty report that they have relevant financial relationships to disclose:

  • Anca D. Askanase, MD, MPH, has served as a consultant for Abbvie and Exagen. She has also done contract research for AstraZeneca, Celgene, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutica, and Pfizer.
  • Robin Dore, MD, has served as a consultant for Amgen, Abbvie, Gilead, Lilly, Radius, and Sanofi. She has been on the speaker’s bureau for Amgen, Abbvie, Lilly, Pfizer, Radius, UCB, and Sanofi and has done research for Amgen, Abbvie, Biogen, Gilead, Lilly, and Pfizer. 
  • Eric L. Matteson, MD, has served as a consultant for Arena Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Inc., Gilead Sciences, and Tympobio.
  • Elizabeth Volkmann, MD, MS, has served as a consultant for Boehringer Ingelheim Pharmaceuticals, Inc., and Forbius.

Accreditation Statement

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit

Physicians
The France Foundation designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
Nurses who are certified by the American Nurses Credentialing Center (ANCC) may utilize activities that are certified by ACCME-accredited providers toward their requirement for certification renewal by the ANCC. A certificate of attendance will be provided by The France Foundation, an ACCME accredited provider.

Method of Participation/How to Receive Credit

  • There are no fees for participating in and receiving credit for this activity.
  • Review the activity objectives and CME/CE information.
  • Complete the CME/CE activity.
  • Complete the online posttest. A score of 100% is required to successfully complete this activity. The participant may take the test until successfully passed.
  • Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  • Credit documentation/reporting:
    • If you are requesting AMA PRA Category 1 Credits™ or a certificate of participation—your CME/CE certificate will be available for download

Statement of Commercial Support

This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Disclaimer Statement/Disclosure of Unlabeled Use

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

Contact Information for Questions About the Activity

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.